About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs


  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank


« USPTO Announces Change in Practice for Correcting Foreign Priority Claims | Main | IPO Webinar on Patent Prosecution After Akamai »

October 21, 2015


Hey Don,

What will be interesting is whether the Federal Circuit will heed the (overwhelming) cry by those supporting the petitioner (Sequenom) and grant an en banc hearing.

I'm not a lawyer but had a hypothetical question and was wondering what the lawyers would think. Suppose a fertilized egg is implanted in a host womb, is the presence of cell free fetal DNA still naturally occurring since the in vitro fertilization procedure was not natural? What about the presence of fetal DNA from the biological mother in the host mothers bloodstream?

The comments to this entry are closed.

April 2024

Sun Mon Tue Wed Thu Fri Sat
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30